Protara Therapeutics, Inc. TARA
Set alert
2.48 USD -0.04 -1.59%
At close · Oct 30
2.52 +0.04 +1.61%
After hours · Oct 30, 4:00 PM ET
2.43 Day range 2.57
2.32 52-week range 7.56
- YTD
- -53.47%
- 1 year
- -51.75%
- Open
- 2.55
- Prev close
- 2.52
- Mkt cap
- 146.56M
- Vol
- 581.16K
- Avg vol
- 969.63K
- EPS
- -1.36
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.43
- High
- 2.57
- Forward P/E
- -1.61
- Beta
- 1.79
- Short ratio
- 14.46
- Inst. own
- 51.11%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.22
- 200-d avg
- 2.74
- 1y target
- 26.40
2Y chart
Events in this range
- Nov 12, 2024Earnings: -0.5; estimate -0.5; surprise 0%
- Nov 14, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 6, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 6, 2024Rating: Guggenheim · Buy → Buy
Signals (100)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| RSI: Oversold | Sep 29, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 18, 2026 | 4 months ago |
| RSI: Oversold | Jun 10, 2026 | 4 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| SMA: Bullish | May 14, 2026 | 5 months ago |
| MACD: Buy Signal | May 14, 2026 | 5 months ago |
| MACD: Sell Signal | May 13, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bullish | Mar 3, 2026 | 8 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 27, 2026 | 8 months ago |
| SMA: Bearish | Feb 24, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 24, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 9, 2026 | 8 months ago |
| RSI: Overbought | Jan 27, 2026 | 9 months ago |
| SMA: Bullish | Jan 21, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 20, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 13, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 9, 2026 | 9 months ago |
| SMA: Bearish | Jan 8, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 3, 2025 | 11 months ago |
| RSI: Overbought | Nov 21, 2025 | 11 months ago |
| RSI: Overbought | Nov 18, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 14, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Nov 6, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 22, 2025 | 1 year ago |
| RSI: Overbought | Oct 13, 2025 | 1 year ago |
| RSI: Overbought | Oct 3, 2025 | 1 year ago |
| SMA: Bullish | Sep 24, 2025 | 1 year ago |
| RSI: Overbought | Sep 24, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 19, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| SMA: Bearish | Sep 16, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 16, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Sep 11, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 11, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 9, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 27, 2025 | 1 year ago |
| SMA: Bullish | Aug 26, 2025 | 1 year ago |
| SMA: Bearish | Aug 19, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Aug 15, 2025 | 1 year ago |
| SMA: Bullish | Aug 13, 2025 | 1 year ago |
| SMA: Bearish | Aug 6, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 31, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 16, 2025 | 1 year ago |
| SMA: Bearish | Jul 10, 2025 | 1 year ago |
| SMA: Bullish | Jul 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 18, 2025 | 1 year ago |
| MACD: Buy Signal | May 19, 2025 | 1 year ago |
| SMA: Bearish | Apr 28, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 23, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 23, 2025 | 1 year ago |
| SMA: Bearish | Apr 16, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| SMA: Bullish | Apr 2, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bullish | Mar 19, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 6, 2025 | 1 year ago |
| RSI: Oversold | Feb 26, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 7, 2025 | 1 year ago |
| SMA: Bearish | Feb 6, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 5, 2025 | 1 year ago |
| SMA: Bullish | Jan 31, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 19, 2024 | 1 year ago |
| RSI: Overbought | Dec 5, 2024 | 1 year ago |
Key statistics
- Market cap
- 176.75M
- Enterprise value
- -31.37M
- Trailing P/E
- 0.00
- Forward P/E
- -1.61
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.86
- EPS (TTM)
- -2.64
- Beta
- 1.79
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -20.31M
- Total cash
- 89.58M
- Total debt
- 4.98M
- Return on equity
- -45.91%
- Shares outstanding
- 34.32M
- Short % of float
- 17.65%
- 50-day average
- 3.22
- 200-day average
- 2.74
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 26.40 +964.5% upside
Now 2.48
- Target (low)
- 14.00
- Target (mean)
- 26.40
- Target (high)
- 50.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.54333.
Financials — quick view
TARA Revenue — quarterly 0
TARA Net income — quarterly -21.67M
TARA EPS — quarterly -0.36
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -0.50 | -0.50 | 0.00 | 0.00% |
| Aug 6, 2024 | Jun 1, 2024 | -0.82 | -0.45 | +0.37 | +45.12% |
| May 2, 2024 | Mar 1, 2024 | -0.99 | -0.97 | +0.02 | +2.02% |
| Mar 13, 2024 | Dec 1, 2023 | -1.03 | -0.90 | +0.13 | +12.62% |
| Nov 3, 2023 | Sep 1, 2023 | -1.10 | -0.87 | +0.23 | +20.91% |
| Aug 3, 2023 | Jun 1, 2023 | -0.97 | -1.00 | -0.03 | -3.09% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 6, 2024 | Guggenheim | reit | Buy | Buy |
| Dec 6, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 12, 2024 | Oppenheimer | main | Outperform | Outperform |
| Aug 8, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 6, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
About Protara Therapeutics, Inc.
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy that is in Phase II clinical trial for patients receiving parenteral nutrition. The company is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- protaratx.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on TARA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BANDARI JATHIN | Officer | Stock Award(Grant) | Jan 18, 2024 | 56,704 |
| FABBIO PATRICK | Chief Financial Officer | Stock Award(Grant) | Jan 18, 2024 | 22,000 |
| FRY HANNAH | Officer | Stock Award(Grant) | Jan 18, 2024 | 29,836 |
| OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 11, 2024 | 0 |
| SHEFFERMAN JESSE M | Chief Executive Officer | Stock Gift | Aug 27, 2024 | 935,501 |
| ZUMMO JACQUELINE | Officer | Stock Award(Grant) | Jan 18, 2024 | 104,296 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RA Capital Management, L.P. | 9.21% | 1,900,000 | 9.79M | Sep 29, 2024 |
| Opaleye Management Inc. | 8.15% | 1,681,154 | 8.66M | Sep 29, 2024 |
| Stempoint Capital LP | 4.57% | 942,857 | 4.86M | Sep 29, 2024 |
| Woodline Partners LP | 4.13% | 851,567 | 4.39M | Sep 29, 2024 |
| Boxer Capital, LLC | 3.93% | 811,627 | 4.18M | Sep 29, 2024 |
| Vanguard Group Inc | 3.68% | 759,612 | 3.91M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.99% | 616,301 | 3.17M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.68% | 140,668 | 724.44K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.47% | 97,351 | 501.36K | Oct 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.24% | 49,200 | 253.38K | Sep 29, 2024 |
| iShares Micro Cap ETF | 0.20% | 41,236 | 212.37K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.15% | 30,335 | 156.22K | Oct 30, 2024 |